Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Human Immunoglobulin (Ph4) For Intravenous Injection industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Grifols
Tiantan Biologic
Shanghai RAAS
Shuanglin Bio-pharmacy
CSL
Shanghai Institute of Biological
Octapharma
Bayer
Sichuan Yuanda Shuyang
China Biologic
Boya Bio-pharmaceutical
By Type:
25g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection
125g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection
5g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection
By Application:
Primary Immunodeficiency Disease
Immune-mediated Thrombocytopenia
Kawasaki Disease
B Chroniclymphocytic Leukemia(B-CLL)
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Human Immunoglobulin (Ph4) For Intravenous Injection Market Overview 2018-2029
-
1.1 China Human Immunoglobulin (Ph4) For Intravenous Injection Industry Development Overview
-
1.2 China Human Immunoglobulin (Ph4) For Intravenous Injection Industry Development History
-
1.3 China Human Immunoglobulin (Ph4) For Intravenous Injection Industry Market Size (2018-2029)
-
1.4 China Human Immunoglobulin (Ph4) For Intravenous Injection Market Analysis by Type from Production Side
-
1.4.1 China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume, Production Value and Growth Rate of 25g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection (2018-2029)
-
1.4.2 China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume, Production Value and Growth Rate of 125g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection (2018-2029)
-
1.4.3 China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume, Production Value and Growth Rate of 5g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection (2018-2029)
-
1.5 China Human Immunoglobulin (Ph4) For Intravenous Injection Market Analysis by Application from Consumption End
-
1.5.1 China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume, Sales Value and Growth Rate of Primary Immunodeficiency Disease (2018-2029)
-
1.5.2 China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume, Sales Value and Growth Rate of Immune-mediated Thrombocytopenia (2018-2029)
-
1.5.3 China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume, Sales Value and Growth Rate of Kawasaki Disease (2018-2029)
-
1.5.4 China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume, Sales Value and Growth Rate of B Chroniclymphocytic Leukemia(B-CLL) (2018-2029)
-
1.6 China Human Immunoglobulin (Ph4) For Intravenous Injection Market Analysis by Region
-
1.6.1 North China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate from 2018-2029
Chapter 2 China Human Immunoglobulin (Ph4) For Intravenous Injection Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Human Immunoglobulin (Ph4) For Intravenous Injection Market Status and Competition at home and abroad in 2023
-
2.2.2 China Human Immunoglobulin (Ph4) For Intravenous Injection Market Status and Competition Analysis in 2023
-
2.2.3 China Human Immunoglobulin (Ph4) For Intravenous Injection Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Human Immunoglobulin (Ph4) For Intravenous Injection Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Human Immunoglobulin (Ph4) For Intravenous Injection Industry Development
Chapter 3 Human Immunoglobulin (Ph4) For Intravenous InjectionIndustry Chain Analysis
-
3.1 Human Immunoglobulin (Ph4) For Intravenous Injection Industry Chain
-
3.2 Human Immunoglobulin (Ph4) For Intravenous Injection Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Human Immunoglobulin (Ph4) For Intravenous Injection Market
-
3.3 Human Immunoglobulin (Ph4) For Intravenous Injection Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Human Immunoglobulin (Ph4) For Intravenous Injection Market
Chapter 4 China Human Immunoglobulin (Ph4) For Intravenous Injection Market, by Type
-
4.1 China Human Immunoglobulin (Ph4) For Intravenous Injection Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Human Immunoglobulin (Ph4) For Intravenous Injection Total Production Volume and Growth Rate from Production Side
-
4.5 China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume and Growth Rate, by Type
-
4.5.1 China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume and Growth Rate of 25g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection
-
4.5.2 China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume and Growth Rate of 125g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection
-
4.5.3 China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume and Growth Rate of 5g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection
Chapter 5 China Human Immunoglobulin (Ph4) For Intravenous Injection Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Human Immunoglobulin (Ph4) For Intravenous Injection Total Market Size and Growth Rate from Consumption End
-
5.5 China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate, by Application
-
5.5.1 China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate of Primary Immunodeficiency Disease
-
5.5.2 China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate of Immune-mediated Thrombocytopenia
-
5.5.3 China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate of Kawasaki Disease
-
5.5.4 China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate of B Chroniclymphocytic Leukemia(B-CLL)
Chapter 6 China Human Immunoglobulin (Ph4) For Intravenous Injection Market, by Region
-
6.1 China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume and Production Value, by Region
-
6.2 China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume and Sales Value, by Region
Chapter 7 North China Human Immunoglobulin (Ph4) For Intravenous Injection Market Analysis
-
7.1 North China Human Immunoglobulin (Ph4) For Intravenous Injection Market, by Type
-
7.2 North China Human Immunoglobulin (Ph4) For Intravenous Injection Market, by Application
Chapter 8 Central China Human Immunoglobulin (Ph4) For Intravenous Injection Market Analysis
-
8.1 Central China Human Immunoglobulin (Ph4) For Intravenous Injection Market, by Type
-
8.2 Central China Human Immunoglobulin (Ph4) For Intravenous Injection Market, by Application
Chapter 9 South China Human Immunoglobulin (Ph4) For Intravenous Injection Market Analysis
-
9.1 South China Human Immunoglobulin (Ph4) For Intravenous Injection Market, by Type
-
9.2 South China Human Immunoglobulin (Ph4) For Intravenous Injection Market, by Application
Chapter 10 East China Human Immunoglobulin (Ph4) For Intravenous Injection Market Analysis
-
10.1 East China Human Immunoglobulin (Ph4) For Intravenous Injection Market, by Type
-
10.2 East China Human Immunoglobulin (Ph4) For Intravenous Injection Market, by Application
Chapter 11 Northeast China Human Immunoglobulin (Ph4) For Intravenous Injection Market Analysis
-
11.1 Northeast China Human Immunoglobulin (Ph4) For Intravenous Injection Market, by Type
-
11.2 Northeast China Human Immunoglobulin (Ph4) For Intravenous Injection Market, by Application
Chapter 12 Southwest China Human Immunoglobulin (Ph4) For Intravenous Injection Market Analysis
-
12.1 Southwest China Human Immunoglobulin (Ph4) For Intravenous Injection Market, by Type
-
12.2 Southwest China Human Immunoglobulin (Ph4) For Intravenous Injection Market, by Application
Chapter 13 Northwest China Human Immunoglobulin (Ph4) For Intravenous Injection Market Analysis
-
13.1 Northwest China Human Immunoglobulin (Ph4) For Intravenous Injection Market, by Type
-
13.2 Northwest China Human Immunoglobulin (Ph4) For Intravenous Injection Market, by Application
Chapter 14 Company Profiles
-
14.1 Grifols
-
14.1.1 Grifols Company Profile
-
14.1.2 Grifols Human Immunoglobulin (Ph4) For Intravenous Injection Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Tiantan Biologic
-
14.2.1 Tiantan Biologic Company Profile
-
14.2.2 Tiantan Biologic Human Immunoglobulin (Ph4) For Intravenous Injection Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Shanghai RAAS
-
14.3.1 Shanghai RAAS Company Profile
-
14.3.2 Shanghai RAAS Human Immunoglobulin (Ph4) For Intravenous Injection Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Shuanglin Bio-pharmacy
-
14.4.1 Shuanglin Bio-pharmacy Company Profile
-
14.4.2 Shuanglin Bio-pharmacy Human Immunoglobulin (Ph4) For Intravenous Injection Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 CSL
-
14.5.1 CSL Company Profile
-
14.5.2 CSL Human Immunoglobulin (Ph4) For Intravenous Injection Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Shanghai Institute of Biological
-
14.6.1 Shanghai Institute of Biological Company Profile
-
14.6.2 Shanghai Institute of Biological Human Immunoglobulin (Ph4) For Intravenous Injection Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Octapharma
-
14.7.1 Octapharma Company Profile
-
14.7.2 Octapharma Human Immunoglobulin (Ph4) For Intravenous Injection Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Bayer
-
14.8.1 Bayer Company Profile
-
14.8.2 Bayer Human Immunoglobulin (Ph4) For Intravenous Injection Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Sichuan Yuanda Shuyang
-
14.9.1 Sichuan Yuanda Shuyang Company Profile
-
14.9.2 Sichuan Yuanda Shuyang Human Immunoglobulin (Ph4) For Intravenous Injection Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 China Biologic
-
14.10.1 China Biologic Company Profile
-
14.10.2 China Biologic Human Immunoglobulin (Ph4) For Intravenous Injection Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Boya Bio-pharmaceutical
-
14.11.1 Boya Bio-pharmaceutical Company Profile
-
14.11.2 Boya Bio-pharmaceutical Human Immunoglobulin (Ph4) For Intravenous Injection Market Performance
-
14.11.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Human Immunoglobulin (Ph4) For Intravenous Injection Industry Research Conclusions
-
15.2 Human Immunoglobulin (Ph4) For Intravenous Injection Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Industry Market Size (2018-2029)
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume, Production Value and Growth Rate of 25g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection (2018-2029)
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume, Production Value and Growth Rate of 125g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection (2018-2029)
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume, Production Value and Growth Rate of 5g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection (2018-2029)
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume, Sales Value and Growth Rate of Primary Immunodeficiency Disease (2018-2029)
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume, Sales Value and Growth Rate of Immune-mediated Thrombocytopenia (2018-2029)
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume, Sales Value and Growth Rate of Kawasaki Disease (2018-2029)
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume, Sales Value and Growth Rate of B Chroniclymphocytic Leukemia(B-CLL) (2018-2029)
-
Figure North China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate from 2018-2029
-
Figure Central China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate from 2018-2029
-
Figure South China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate from 2018-2029
-
Figure East China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate from 2018-2029
-
Figure Human Immunoglobulin (Ph4) For Intravenous Injection Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Market Share by Type in 2018
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Market Share by Type in 2023
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume and Growth Rate of 25g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection (2018-2023)
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume and Growth Rate of 125g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection (2018-2023)
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume and Growth Rate of 5g/Bottle Human Immunoglobulin (pH4) for Intravenous Injection (pH4) for Intravenous Injection (2018-2023)
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Market Share by Application in 2018
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Market Share by Application in 2023
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Total Market Size and Growth Rate from Consumption End
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate of Primary Immunodeficiency Disease (2018-2023)
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate of Immune-mediated Thrombocytopenia (2018-2023)
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate of Kawasaki Disease (2018-2023)
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Market Size and Growth Rate of B Chroniclymphocytic Leukemia(B-CLL) (2018-2023)
-
Table China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume by Region (2018-2023)
-
Table China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume Share by Region (2018-2023)
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume Share by Region (2018-2023)
-
Table China Human Immunoglobulin (Ph4) For Intravenous Injection Production Value by Region (2018-2023)
-
Table China Human Immunoglobulin (Ph4) For Intravenous Injection Production Value Share by Region (2018-2023)
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Production Value Share by Region (2018-2023)
-
Table China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume by Region (2018-2023)
-
Table China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume Share by Region (2018-2023)
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume Share by Region (2018-2023)
-
Table China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Value by Region (2018-2023)
-
Table China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Value Share by Region (2018-2023)
-
Figure China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Value Share by Region (2018-2023)
-
Table North China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume by Type (2018-2023)
-
Table North China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume Share by Type (2018-2023)
-
Figure North China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume Share by Type (2018-2023)
-
Table North China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume by Application (2018-2023)
-
Table North China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Figure North China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Table Central China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume by Type (2018-2023)
-
Table Central China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume Share by Type (2018-2023)
-
Figure Central China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume Share by Type (2018-2023)
-
Table Central China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume by Application (2018-2023)
-
Table Central China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Figure Central China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Table South China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume by Type (2018-2023)
-
Table South China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume Share by Type (2018-2023)
-
Figure South China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume Share by Type (2018-2023)
-
Table South China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume by Application (2018-2023)
-
Table South China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Figure South China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Table East China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume by Type (2018-2023)
-
Table East China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume Share by Type (2018-2023)
-
Figure East China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume Share by Type (2018-2023)
-
Table East China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume by Application (2018-2023)
-
Table East China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Figure East China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Table Northeast China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume by Type (2018-2023)
-
Table Northeast China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume Share by Type (2018-2023)
-
Figure Northeast China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume Share by Type (2018-2023)
-
Table Northeast China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume by Application (2018-2023)
-
Table Northeast China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Table Southwest China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume by Type (2018-2023)
-
Table Southwest China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume Share by Type (2018-2023)
-
Figure Southwest China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume Share by Type (2018-2023)
-
Table Southwest China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume by Application (2018-2023)
-
Table Southwest China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Table Northwest China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume by Type (2018-2023)
-
Table Northwest China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume Share by Type (2018-2023)
-
Figure Northwest China Human Immunoglobulin (Ph4) For Intravenous Injection Production Volume Share by Type (2018-2023)
-
Table Northwest China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume by Application (2018-2023)
-
Table Northwest China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Human Immunoglobulin (Ph4) For Intravenous Injection Sales Volume Share by Application (2018-2023)
-
Table Grifols Company Profile
-
Table Grifols Human Immunoglobulin (Ph4) For Intravenous Injection Revenue, Price and Gross (2018-2023)
-
Table Tiantan Biologic Company Profile
-
Table Tiantan Biologic Human Immunoglobulin (Ph4) For Intravenous Injection Revenue, Price and Gross (2018-2023)
-
Table Shanghai RAAS Company Profile
-
Table Shanghai RAAS Human Immunoglobulin (Ph4) For Intravenous Injection Revenue, Price and Gross (2018-2023)
-
Table Shuanglin Bio-pharmacy Company Profile
-
Table Shuanglin Bio-pharmacy Human Immunoglobulin (Ph4) For Intravenous Injection Revenue, Price and Gross (2018-2023)
-
Table CSL Company Profile
-
Table CSL Human Immunoglobulin (Ph4) For Intravenous Injection Revenue, Price and Gross (2018-2023)
-
Table Shanghai Institute of Biological Company Profile
-
Table Shanghai Institute of Biological Human Immunoglobulin (Ph4) For Intravenous Injection Revenue, Price and Gross (2018-2023)
-
Table Octapharma Company Profile
-
Table Octapharma Human Immunoglobulin (Ph4) For Intravenous Injection Revenue, Price and Gross (2018-2023)
-
Table Bayer Company Profile
-
Table Bayer Human Immunoglobulin (Ph4) For Intravenous Injection Revenue, Price and Gross (2018-2023)
-
Table Sichuan Yuanda Shuyang Company Profile
-
Table Sichuan Yuanda Shuyang Human Immunoglobulin (Ph4) For Intravenous Injection Revenue, Price and Gross (2018-2023)
-
Table China Biologic Company Profile
-
Table China Biologic Human Immunoglobulin (Ph4) For Intravenous Injection Revenue, Price and Gross (2018-2023)
-
Table Boya Bio-pharmaceutical Company Profile
-
Table Boya Bio-pharmaceutical Human Immunoglobulin (Ph4) For Intravenous Injection Revenue, Price and Gross (2018-2023)
-
